US · guidance
CMS SOM App. L, Tag Q-0242
§416.51(b) Standard: Infection control program
The ASC must maintain an ongoing program designed to prevent, control, and
investigate infections and communicable diseases. In addition, the infection control
and prevention program must include documentation that the ASC has considered,
selected, and implemented nationally recognized infection control guidelines. […]
Interpretive Guidelines: §416.51(b)
The ASC must maintain an ongoing program to prevent, control, and investigate
infections and communicable diseases. As part of this ongoing program, the ASC must
have an active surveillance component that covers both ASC patients and personnel
working in the facility. Surveillance includes infection detection through ongoing data
collection and analysis.
The ongoing program must be based on nationally recognized infection control
guidelines that the ASC has selected, after a deliberative process. Examples of national
organizations that promulgate nationally recognized infection and communicable disease
control guidelines, and/or recommendations include: the Centers for Disease Control and
Prevention (CDC), the Association for Professionals in Infection Control and
Epidemiology (APIC), the Society for Healthcare Epidemiology of America (SHEA), and
the Association of periOperative Registered Nurses (AORN).
The ASC should select one or more sets of guidelines that enable it to address the
following key functions of an effective infection control program:
• Maintenance of a sanitary ASC environment (see requirements of §416.51(a));
• Development and implementation of infection control activities related to ASC
personnel, which, for infection control purposes, includes all ASC medical staff,
employees, and on-site contract workers (e.g., nursing staff employed by
associated physician practice who also work in the ASC, housekeeping staff, etc);
• Mitigation of risks associated healthcare-associated infections:
• Identifying infections;
• Monitoring compliance with all policies, procedures, protocols and other infection
control program requirements;
• Program evaluation and revision of the program, when indicated;
The following provides a more detailed overview of the types of activities related to these
key functions.
ASC staff-related activities:
• Evaluating ASC staff immunization status for designated infectious diseases, for
example, as recommended by the CDC and its Advisory Committee on
Immunization Practices (ACIP);
• Policies articulating the authority and circumstances under which the ASC screens
its staff for infections likely to cause significant infectious disease or other risk to
the exposed individual, and for reportable diseases, as required under local, state,
or federal public health authority;
• Policies articulating when infected ASC staff are restricted from providing direct
patient care or required to remain away from the facility entirely;
• New employee and regular update training in preventing and controlling
healthcare-associated infections and methods to prevent exposure to and
transmission of infections and communicable diseases; and
• Methods to evaluate staff exposed to patients with infections and communicable
diseases.
Mitigation of risks contributing to healthcare-associated infections (HAI):
For the purposes of its surveillance activities in an acute care setting, the CDC defines an
HAI as a localized or systemic condition resulting from an adverse reaction to the
presence of an infectious agent(s) or its toxin(s). There must be no evidence that the
infection was present or incubating at the time of admission to the ASC.
HAIs may be caused by infectious agents from endogenous or exogenous sources.
Endogenous sources are body sites, such as the skin, nose, mouth, gastrointestinal (GI)
tract, or vagina that are normally inhabited by microorganisms. Exogenous sources are
those external to the patient, such as patient care personnel, visitors, patient care
equipment, medical devices, or the health care environment.
HAI risk mitigation measures include:
Surgery-related infection risk mitigation measures:
• Implementing appropriate prophylaxis to prevent surgical site infection (SSI),
such as protocol to assure that antibiotic prophylaxis to prevent SSI for
appropriate procedures is administered at the appropriate time, done with an
appropriate antibiotic, and discontinued appropriately after surgery; and
• Addressing aseptic technique practices used in surgery, including sterilization or
high-level disinfection of instruments, as appropriate.
• Other ASC healthcare-associated infection risk mitigation measures:
• Promotion of hand hygiene among staff and employees, including utilization of
alcohol-based hand sanitizers;
• Measures specific to the prevention of infections caused by organisms that are
antibiotic-resistant;
• Measures specific to safe practices for injecting medications and saline or other
infusates;
• Requiring disinfectants and germicides to be used in accordance with the
manufacturers’ instructions;
• Appropriate use of facility and medical equipment, including air filtration
equipment, UV lights, and other equipment used to control the spread of
infectious agents;
• Educating patients, visitors, and staff, as appropriate, about infections and
communicable diseases and methods to reduce transmission in the ASC and in the
community.
Identifying Infections
The ASC must conduct monitoring activities throughout the entire facility in order to
identify infection risks or communicable disease problems. The ASC should document
its monitoring/tracking activities, including the measures selected for monitoring, and
collection and analysis methods. Activities should be conducted in accordance with
recognized infection control surveillance practices, such as, for example, those utilized by
the CDC’s National Healthcare Safety Net (NHSN). Monitoring includes follow-up of
patients after discharge, in order to gather evidence of whether they have developed an
infection associated with their stay in the ASC.
The ASC must develop and implement appropriate infection control interventions to
address issues identified through its detection activities, and then monitor the
effectiveness of interventions through further data collection and analysis.
Monitoring Compliance
It is not sufficient for the ASC to have detailed policies and procedures governing
infection control; it must also take steps to determine whether the staff of the ASC adhere
to these policies and procedures in practice. Are staff washing their hands prior to
providing care to patients? Do personnel who prepare injections comply with all
pertinent protocols? Is equipment properly sterilized or disinfected? Is the facility clean?
The ASC must demonstrate that it has a process in place for regularly assessing infection
control compliance.
Program Evaluation
See the guidance for §416.51(b)(2), which requires that the infection control program
must be an integral part of the ASC's quality assessment and performance improvement
program.
An ASC presents different challenges for infection control as patients at varying levels of
wellness are gathered in waiting or recovery areas, including the elderly, immuno-compromised patients, pre- and post-operative patients, and individuals with active or
incubating infectious and communicable diseases. The length of stay for such individuals
can range from brief to all day. Additionally, as ASCs are performing more invasive
procedures, the level of risk for developing and transmitting infections and
communicable diseases for patients and heath care workers increases. The ASC should
design its infection control program with these challenges in mind. For instance, the
ASC should take appropriate control measures for those individuals who may present risk
for the transmission of infectious agents by the airborne or droplet route. When such
individuals are identified, the ASC could, for example, implement such prevention
measures that would include prompt physical separation, implementation of respiratory
hygiene/cough etiquette protocols, and appropriate isolation precautions based on the
routes of transmission of the suspected infection.
Survey Procedures: §416.51(b)
• Use the infection control tool to assist in assessing compliance with this standard.
• Determine that there is an ongoing program for the prevention, control, and
investigation of infections and communicable diseases among patients and ASC
personnel, including contract workers and volunteers.
• Determine whether the policies and procedures of the program of the infection
control program are implemented correctly. Specifically, surveyors should
determine whether the ASC:
• Mitigates risks contributing to healthcare-associated infections (for example,
observe whether staff exhibit good hand hygiene);
• Performs monitoring/tracking activities to identify infections; and
• Monitors compliance with all infection control program requirements.
• Review the parameters of the program to determine whether it is consistent with
nationally recognized infection control guidelines. Is there documentation that
the ASC has developed the procedures and policies of the program based on
nationally recognized infection control guidelines?
History
Rev. 206; Issued: 06-17-22; Effective: 06-17-22; Implementation: 06-17-22
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
2c90e261acbdfc9e9061e25ad89f349165a1c2a0a959fe385134f7f5ed7bf0a5
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.